Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to -$803000.0.

  • Beauty Health's Cash from Financing Activities fell 29362.75% to -$803000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$175.2 million, marking a year-over-year increase of 727.47%. This contributed to the annual value of -$158.3 million for FY2024, which is 32282.9% down from last year.
  • Beauty Health's Cash from Financing Activities amounted to -$803000.0 in Q3 2025, which was down 29362.75% from -$173.4 million recorded in Q2 2025.
  • In the past 5 years, Beauty Health's Cash from Financing Activities registered a high of $637.8 million during Q3 2021, and its lowest value of -$173.4 million during Q2 2025.
  • Moreover, its 5-year median value for Cash from Financing Activities was -$1.5 million (2023), whereas its average is $20.2 million.
  • As far as peak fluctuations go, Beauty Health's Cash from Financing Activities soared by 249706523.1% in 2021, and later plummeted by 628738.68% in 2024.
  • Beauty Health's Cash from Financing Activities (Quarter) stood at $188.2 million in 2021, then tumbled by 154.45% to -$102.5 million in 2022, then soared by 69.4% to -$31.4 million in 2023, then soared by 97.54% to -$770000.0 in 2024, then dropped by 4.29% to -$803000.0 in 2025.
  • Its Cash from Financing Activities stands at -$803000.0 for Q3 2025, versus -$173.4 million for Q2 2025 and -$250000.0 for Q1 2025.